NewsBenzingaRBC Capital ribadisce il giudizio Outperform su Microsoft, mantiene il target di prezzo di 640 dollari RBC Capital ribadisce il giudizio Outperform su Microsoft, mantiene il target di prezzo di 640 dollari Benzinga 2026.10.29 20:21 (GMT+0) Open on Benzinga Other news CORRECTION: Alignment Healthcare Raises FY2026 Sales Guidance from $5.195B-$5.225B to $5.245B vs $5.218B Est CORRECTION: Alignment Healthcare Sees Q4 Sales $1.316B vs $1.335B Est GATX Corporation (GATX) Q3 2026 Earnings Call Transcript Grupo Televisa Q3 EPS $0.09 Beats $0.03 Estimate, Sales $815.845M Miss $837.810M Estimate West Bancorporation, Inc. (WTBA) Q3 2026 Earnings Call Transcript Canaccord Genuity Maintains Buy on Wave Life Sciences, Raises Price Target to $44
CORRECTION: Alignment Healthcare Raises FY2026 Sales Guidance from $5.195B-$5.225B to $5.245B vs $5.218B Est
